Efficacy of the fixed-dose combination of valsartan 160/HCTZ 25 in hypertensive patients not controlled by the combination of candesartan 32/HCTZ 25 - The Cicero trial

被引:0
|
作者
Schweizer, J.
Hilsmann, U.
Neumann, G.
Handrock, R.
Klebs, S.
机构
[1] Chemnitz Hosp, Chemnitz, Germany
[2] Practice Internal Med, Dortmund, Germany
[3] Practice Internal Med, Delitzsch, Germany
[4] Novartis Pharma GmbH, Nurnberg, Germany
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:S228 / S228
页数:1
相关论文
共 50 条
  • [21] EFFECTIVENESS OF LOSARTAN 50 MG/HCTZ 12.5 MG VERSUS VALSARTAN 80 MG/HCTZ 12.5 MG TITRATED AS NEEDED TO LOSARTAN 100 MG/HCTZ 25 MG AND VALSARTAN 160/HCTZ 25 MG, IN PATIENTS WITH ESSENTIAL HYPERTENSION WHO HAVE NOT REACHED TARGET BLOOD PRESSURE WITH MONOTHERAPY: THE BP-EASE TRIAL
    Hamet, P.
    Duong, A.
    Snape, S.
    Sampalis, J. S.
    Bastien, N.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 39D - 39D
  • [22] Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with HypertensionFocus on Amlodipine/Valsartan
    Pedro Marques da Silva
    Clinical Drug Investigation, 2010, 30 : 625 - 641
  • [23] Chronotherapy with valsartan-HCTZ combination in hypertensive patients: Improved blood pressure regulation after bedtime administration
    Hermida, R. C.
    Calvo, C.
    Ayala, D. E.
    Rodriguez, M.
    Chayan, L.
    Lopez, J. E.
    Mojon, A.
    Fernandez, J. R.
    JOURNAL OF HYPERTENSION, 2006, 24 : S89 - S89
  • [24] Chronotherapy with valsartan-HCTZ combination in hypertensive patients: Improved blood pressure regulation after bedtime administration
    Hermida, Ramon
    Calvo, Carlos
    Ayala, Diana
    Lopez, Jose
    Rodriguez, Marta
    Chayan, Luisa
    Mojon, Artemio
    Fernandez, Jose
    JOURNAL OF HYPERTENSION, 2006, 24 : 257 - 258
  • [25] Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with Hypertension Focus on Amlodipine/Valsartan
    da Silva, Pedro Marques
    CLINICAL DRUG INVESTIGATION, 2010, 30 (09) : 625 - 641
  • [26] Chronotherapy with valsartan-HCTZ combination in hypertensive patients:: Improved blood pressure regulation with bedtime administration.
    Calvo, C.
    Hermida, R. C.
    Ayala, D. E.
    Rodríguez, M.
    Chayán, L.
    López, J. E.
    Mojón, A.
    Fernández, J. R.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 134 - 134
  • [27] Clinical Outcomes and Healthcare Costs in Hypertensive Patients Treated With a Fixed-Dose Combination of Amlodipine/Valsartan
    Tung, Ying-Chang
    Lin, Yu-Sheng
    Wu, Lung-Sheng
    Chang, Chee-Jen
    Chu, Pao-Hsien
    JOURNAL OF CLINICAL HYPERTENSION, 2015, 17 (01): : 51 - 58
  • [28] Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal
    Maldonado J.
    Pereira T.
    Tavares A.
    Drugs in R&D, 2014, 14 (2) : 147 - 154
  • [29] Efficacy and Safety of a Lecarnidipine-Enalapril Fixed-Dose Combination in Hypertensive Patients
    Joao, Maldonado
    Telmo, Pereira
    JOURNAL OF CLINICAL HYPERTENSION, 2013, 15
  • [30] Prolonged treatment with full dose HCTZ (25 mg/d) aggravates arterial compliance (AC) and metabolic parameters while treatment of hypertensive patients with low dose HCTZ
    Shargorodsky, M
    Wainstein, J
    Davidovitz, I
    Boaz, M
    Gavish, D
    Leibovitz, E
    Zimlichman, R
    JOURNAL OF HYPERTENSION, 2004, 22 : S203 - S203